# Citi Trends Inc: financial statements, quarterly

CTRN · Nasdaq · CIK 1318484 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 30

Pages: [Overview](/companies/ctrn.md) · [Financials](/companies/ctrn/financials.md) · [Filings](/companies/ctrn/filings.md) · [Insiders](/companies/ctrn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ctrn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [180](/filings/0001558370-24-016152.md) | [215 d](/filings/0001104659-26-043813.md) | [186](/filings/0001558370-25-008535.md) | [177](/filings/0001558370-25-011991.md) | [179](/filings/0001104659-25-119960.md) | [211 d](/filings/0001104659-26-043813.md) | [202](/filings/0001104659-26-072225.md) | [191](/filings/0001104659-26-106249.md) | [197](/filings/0001104659-25-119960.md) | [230 d](/filings/0001104659-26-043813.md) | [231](/filings/0001104659-26-072225.md) | [212](/filings/0001104659-26-106249.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [69.7](/filings/0001558370-24-016152.md) | [74.5 d](/filings/0001104659-26-043813.md) | [74.2](/filings/0001558370-25-008535.md) | [73.8](/filings/0001558370-25-011991.md) | [74.7](/filings/0001104659-25-119960.md) | [77.5 d](/filings/0001104659-26-043813.md) | [74.9](/filings/0001104659-26-072225.md) | [78.9](/filings/0001104659-26-106249.md) | [79.3](/filings/0001104659-25-119960.md) | [80.0 d](/filings/0001104659-26-043813.md) | [79.7](/filings/0001104659-26-072225.md) | [82.3](/filings/0001104659-26-106249.md) |
| Operating income | $m | [(6.0)](/filings/0001558370-24-016152.md) | [3.9 d](/filings/0001104659-26-043813.md) | [(7.0)](/filings/0001558370-25-008535.md) | [(24.9)](/filings/0001558370-25-011991.md) | [(8.8)](/filings/0001104659-25-119960.md) | [1.2 d](/filings/0001104659-26-043813.md) | [0.5](/filings/0001104659-26-072225.md) | [3.5](/filings/0001104659-26-106249.md) | [(7.3)](/filings/0001104659-25-119960.md) | [7.2 d](/filings/0001104659-26-043813.md) | [7.4](/filings/0001104659-26-072225.md) | [(1.7)](/filings/0001104659-26-106249.md) |
| Interest expense | $m | [0.1](/filings/0001558370-23-019509.md) | [0.1 d](/filings/0001558370-24-005294.md) | [0.1](/filings/0001558370-24-009085.md) | [0.1](/filings/0001558370-25-011991.md) | [0.1](/filings/0001104659-25-119960.md) | [0.1 d](/filings/0001104659-26-043813.md) | [0.1](/filings/0001104659-26-072225.md) | [0.1](/filings/0001104659-26-106249.md) | [0.1](/filings/0001104659-25-119960.md) | [0.1 d](/filings/0001104659-26-043813.md) | [0.1](/filings/0001104659-26-072225.md) | [0.1](/filings/0001104659-26-106249.md) |
| Income tax | $m | [(1.3)](/filings/0001558370-24-016152.md) | [1.4 d](/filings/0001104659-26-043813.md) | [(2.8)](/filings/0001558370-25-008535.md) | [(6.0)](/filings/0001558370-25-011991.md) | [(1.3)](/filings/0001104659-25-119960.md) | [15.8 d](/filings/0001104659-26-043813.md) | not reported | not reported | not reported | not reported | [0.2](/filings/0001104659-26-072225.md) | [(0.3)](/filings/0001104659-26-106249.md) |
| Net income | $m | [(3.9)](/filings/0001558370-24-016152.md) | [3.6 d](/filings/0001104659-26-043813.md) | [(3.4)](/filings/0001104659-25-119960.md) | [(18.4)](/filings/0001104659-25-119960.md) | [(7.2)](/filings/0001104659-25-119960.md) | [(14.2) d](/filings/0001104659-26-043813.md) | [0.9](/filings/0001104659-26-106249.md) | [3.8](/filings/0001104659-26-106249.md) | [(6.9)](/filings/0001104659-25-119960.md) | [7.4 d](/filings/0001104659-26-043813.md) | [7.8](/filings/0001104659-26-106249.md) | [(0.9)](/filings/0001104659-26-106249.md) |
| Diluted EPS | $ per share | [(0.47)](/filings/0001558370-24-016152.md) | not reported | [(0.42)](/filings/0001558370-25-008535.md) | [(2.21)](/filings/0001558370-25-011991.md) | [(0.86)](/filings/0001104659-25-119960.md) | not reported | [0.11](/filings/0001104659-26-072225.md) | [0.46](/filings/0001104659-26-106249.md) | [(0.86)](/filings/0001104659-25-119960.md) | not reported | [0.91](/filings/0001104659-26-072225.md) | [(0.11)](/filings/0001104659-26-106249.md) |
| Basic EPS | $ per share | [(0.47)](/filings/0001558370-24-016152.md) | not reported | [(0.42)](/filings/0001558370-25-008535.md) | [(2.21)](/filings/0001558370-25-011991.md) | [(0.86)](/filings/0001104659-25-119960.md) | not reported | [0.11](/filings/0001104659-26-072225.md) | [0.48](/filings/0001104659-26-106249.md) | [(0.86)](/filings/0001104659-25-119960.md) | not reported | [0.95](/filings/0001104659-26-072225.md) | [(0.11)](/filings/0001104659-26-106249.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic, us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-28) | FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [204](/filings/0001558370-23-019509.md) | [225](/filings/0001558370-25-004897.md) | [195](/filings/0001558370-24-009085.md) | [215](/filings/0001558370-24-012737.md) | [183](/filings/0001558370-24-016152.md) | [197](/filings/0001104659-26-043813.md) | [169](/filings/0001558370-25-008535.md) | [189](/filings/0001558370-25-011991.md) | [192](/filings/0001104659-25-119960.md) | [193](/filings/0001104659-26-106249.md) | [213](/filings/0001104659-26-072225.md) | [203](/filings/0001104659-26-106249.md) |
| Total assets | $m | [508](/filings/0001558370-23-019509.md) | [519](/filings/0001558370-25-004897.md) | [484](/filings/0001558370-24-009085.md) | [507](/filings/0001558370-24-012737.md) | [467](/filings/0001558370-24-016152.md) | [463](/filings/0001104659-26-043813.md) | [437](/filings/0001558370-25-008535.md) | [457](/filings/0001558370-25-011991.md) | [464](/filings/0001104659-25-119960.md) | [471](/filings/0001104659-26-106249.md) | [496](/filings/0001104659-26-072225.md) | [487](/filings/0001104659-26-106249.md) |
| Current liabilities | $m | [156](/filings/0001558370-23-019509.md) | [170](/filings/0001558370-25-004897.md) | [143](/filings/0001558370-24-009085.md) | [185](/filings/0001558370-24-012737.md) | [160](/filings/0001558370-24-016152.md) | [174](/filings/0001104659-26-043813.md) | [150](/filings/0001558370-25-008535.md) | [167](/filings/0001558370-25-011991.md) | [180](/filings/0001104659-25-119960.md) | [173](/filings/0001104659-26-106249.md) | [186](/filings/0001104659-26-072225.md) | [179](/filings/0001104659-26-106249.md) |
| Total liabilities | $m | [355](/filings/0001558370-23-019509.md) | [361](/filings/0001558370-25-004897.md) | [329](/filings/0001558370-24-009085.md) | [370](/filings/0001558370-24-012737.md) | [337](/filings/0001558370-24-016152.md) | [350](/filings/0001104659-26-043813.md) | [329](/filings/0001558370-25-008535.md) | [344](/filings/0001558370-25-011991.md) | [356](/filings/0001104659-25-119960.md) | [355](/filings/0001104659-26-106249.md) | [371](/filings/0001104659-26-072225.md) | [362](/filings/0001104659-26-106249.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [153](/filings/0001558370-24-016152.md) | [158](/filings/0001104659-26-043813.md) | [155](/filings/0001104659-25-119960.md) | [137](/filings/0001104659-25-119960.md) | [130](/filings/0001104659-25-119960.md) | [113](/filings/0001104659-26-106249.md) | [109](/filings/0001104659-26-106249.md) | [113](/filings/0001104659-26-106249.md) | [108](/filings/0001104659-25-119960.md) | [116](/filings/0001104659-26-106249.md) | [125](/filings/0001104659-26-106249.md) | [125](/filings/0001104659-26-106249.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(2.9) d](/filings/0001558370-24-016152.md) | [23.3 d](/filings/0001104659-26-043813.md) | [(19.6)](/filings/0001558370-25-008535.md) | [5.6 d](/filings/0001558370-25-011991.md) | [(18.4) d](/filings/0001104659-25-119960.md) | [28.5 d](/filings/0001104659-26-043813.md) | [(11.0)](/filings/0001104659-26-072225.md) | [3.9 d](/filings/0001104659-26-106249.md) | [8.6 d](/filings/0001104659-25-119960.md) | [19.5 d](/filings/0001104659-26-043813.md) | [20.9](/filings/0001104659-26-072225.md) | [(14.2) d](/filings/0001104659-26-106249.md) |
| Capital expenditure | $m | [4.7 d](/filings/0001558370-24-016152.md) | [3.3 d](/filings/0001104659-26-043813.md) | [1.6](/filings/0001558370-25-008535.md) | [4.0 d](/filings/0001558370-25-011991.md) | [2.1 d](/filings/0001104659-25-119960.md) | [2.5 d](/filings/0001104659-26-043813.md) | [2.1](/filings/0001104659-26-072225.md) | [5.6 d](/filings/0001104659-26-106249.md) | [7.8 d](/filings/0001104659-25-119960.md) | [4.8 d](/filings/0001104659-26-043813.md) | [5.8](/filings/0001104659-26-072225.md) | [9.8 d](/filings/0001104659-26-106249.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [6.3](/filings/0001104659-26-072225.md) | [0.0 d](/filings/0001104659-26-106249.md) | [0.0 d](/filings/0001104659-25-119960.md) | [0.0 d](/filings/0001104659-26-043813.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-10-29) | Q1 FY2023 (2023-04-29) | Q2 FY2023 (2023-07-29) | Q3 FY2023 (2023-10-28) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [8,145](/filings/0001558370-23-019509.md) | [8,182](/filings/0001558370-24-009085.md) | [8,225](/filings/0001558370-24-012737.md) | [8,238](/filings/0001558370-24-016152.md) | [8,253](/filings/0001558370-25-008535.md) | [8,337](/filings/0001558370-25-011991.md) | [8,356](/filings/0001104659-25-119960.md) | [8,170](/filings/0001104659-26-072225.md) | [8,314](/filings/0001104659-26-106249.md) | [8,050](/filings/0001104659-25-119960.md) | [8,484](/filings/0001104659-26-072225.md) | [8,183](/filings/0001104659-26-106249.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 8,339,447 at 2026-08-28, from the cover of the [10-Q filed 2026-09-09](/filings/0001104659-26-106249.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.